on invasive imaging of [18F]HX4 with Positron-Emission-Tomography (PET) in Cervix Cancer.

Phase 2

Withdrawn

• Conditions: cervix cancer; 10038594

• Registration Number: NL-OMON37407
• Lead Sponsor: Medisch Universitair Ziekenhuis Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

-Histological or cytological confirmed Cervix squamous cell carcinoma, adenocarcinoma or adenosquamous carcinoma of Uterine Cervix;
-tumor stages FIGO Ib - IVa;
-WHO performance status 0 to 2;
-Scheduled for primary curative radiotherapy (either or not combined with chemotherapy or hyperthermia);
- willing to take adequate contraceptive measures during the study
- The patient is willing and capable to comply with study procedures;
- 18 years or older;
-Have given written informed consent before patient registration;
- no previous surgery to the Cervix;
- no previous radiation to the Cervix;

Exclusion Criteria

recent < 3 maanden) myocard infarct;
- uncontrolled infectious disease;
- pregnant or breast feeding and/ or not willing to take adequate contraceptive measures

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary endpoint: Tumor to background ratio of [18F] HX4 PET images.</p><br>